Dysregulation of apoptosis may be closely related to the development of cancer and its chemoresistance. Overexpression of Bax, an inducer of apoptosis, has led to increased cell death in a variety of cancer cell lines. In this study, we investigated the effect of Bax overexpression in two gastric cancer cell lines, MKN-28 and MKN-45, using a Cre-loxP-mediated inducible expression system. After induction of bax, both cell lines showed decreased proliferation, partially due to increased cell death. Furthermore, Bax-expressing MKN-28 cells were more sensitive to cisplatin. These results indicate that up-regulation of the bax gene may provide a novel strategy for the treatment of gastric cancer. Cancer Gene Therapy (2000) 7, 885-892
A n increased understanding of the genes involved in the regulation of apoptosis (or programmed cell death) has led to the hypothesis that dysregulation of apoptosis underlies tumor development, progression, and its resistance to therapies. 1 Thus, therapies directed at altering the levels of expression of apoptosis-regulating genes to increase the cell death response may be a useful strategy for treating cancer. Therefore, it is important to know the effects of modulating these genes in cancer cells.
Members of the bcl-2 gene family, including bcl-2, bcl-X, bax, bad, and others, play a crucial role in the regulation of apoptosis. 2 The members of this family act as either inducers or inhibitors of apoptosis by controlling each other's homo-or heterodimerization. In particular, the Bax protein has been postulated to accelerate apoptosis and to counter the death repressor function of Bcl-2, and a model has been proposed in which the ratio of Bcl-2 to Bax determines whether or not the apoptotic pathway progresses. 2, 3 Genetic alterations in these genes are often observed in gastric cancer. 4 -8 Therefore, bcl-2 and bax may be closely related to the ability of gastric cancer cells to survive.
There have been several studies on the effect of enhancing Bax expression in cancer cells. It has been shown that Bax has a tumor suppressor function in a transgenic mouse brain tumor model 9 and in breast cancer cells transplanted in severe combined immunodeficient mice, 10 and gene transfer of bax results in strong antitumoral activity in non-small cell lung cancer in vivo. 11 Several studies have shown that overexpressed Bax enhanced apoptosis after treatment with chemotherapeutic agents in human breast cancer cells, 12, 13 ovarian cancer cells, 14 erythroleukemia cells, 15 and rat glioma cells, 16 and after treatment with radiation in human breast cancer cells. 17 However, the effect of enhanced Bax expression in gastric cancer has not been reported.
In the present study, we examined the effects of induced Bax overexpression in gastric cancer cells, rather than the effects of stable Bax overexpression. We used the Cre-loxP-mediated site-specific recombination system to regulate bax gene expression. 18 This system can be used to turn on the expression of a transgene that has been integrated into the host chromosomes in a silent form, by infecting cells with a Cre-expressing adenovirus (Ad) vector. 19 We applied this system to two gastric cancer cell lines: MKN-28 cells, which overexpress Bcl-2 protein and have a mutation in the p53 gene, and MKN-45 cells, which lack a detectable level of Bcl-2 protein and have the wild-type p53 gene. 5, 20 Our study shows that overexpressed Bax reduces the growth rate of these cells and sensitizes MKN-28 cells to cisplatin (CDDP).
MATERIALS AND METHODS

Cells and culture conditions
Two human gastric cancer cell lines, MKN-28 and MKN-45, were purchased from the Japanese Cancer Research Re-sources Bank (Tokyo, Japan). Cells were maintained in Dulbecco's modified Eagle's medium (Sigma, St. Louis, Mo), 10% heat-inactivated fetal bovine sera (Life Technologies, Karlsruhe, Germany), 2 mM L-glutamine, and 1% penicillinstreptomycin.
Gastric cancer cell lines MKN-45 and MKN-28 stably transfected with inducible bax
The plasmid pCAG-CAT-bax-neo was constructed as follows: Human Bax-␣ full-length cDNA was produced by reverse transcriptase-polymerase chain reaction (RT-PCR), and inserted into the EcoRI site of pCY4B, a derivative of the pCAGGS expression vector. 21 The sequence of the Bax-␣ cDNA was confirmed. The loxP-CAT-loxP unit (loxP-flanked chloramphenicol acetyl-transferase (CAT) gene) was cut out at the XbaI-BamHI site of the pCAG-CAT-Z plasmid 22 (kindly provided by Dr. Araki, Kumamoto University School of Medicine, Kumamoto, Japan), and inserted into the XbaI-HindIII site between the promoter and the Bax cDNA of pCY4B-Bax. The neomycin-resistance gene, under control of the thymidine kinase gene promoter, was inserted into the SalI site of the plasmid, resulting in pCAG-CAT-bax-neo. MKN-45 and MKN-28 cells were seeded into 10-cm dishes and transfected 20 hours later with 20 g/dish of this plasmid DNA by calcium-phosphate coprecipitation. 23 Cells were washed after 24 hours and fed with 10 mL of fresh medium. After another 24 hours, the medium was changed to the selective medium containing 400 g/mL active G418. The resulting G418-resistant clones that were derived from MKN-45 and MKN-28 were isolated. The amount of CAT in the extracts from these cells was determined using the CAT enzyme-linked immunosorbent assay kit (Boehringer Mannheim, Mannheim, Germany). The protein concentration of the cell extracts was determined using a protein assay kit (Bio-Rad, Richmond, Calif). Two stable transfectants, 45CB1 and 28CB2, derived from MKN-45 and MKN-28, respectively, were shown to produce Bax mRNA upon infection with the Cre-expressing Ad vector, AdCAGCre, 19 and were used in the following study.
Ad vector infection
As a control for the Ad-mediated gene transfer, Adex1CAlacZ, 24 a ␤-galactosidase (␤-gal)-expressing Ad vector under the transcriptional control of the ␤-actin promoter and cytomegalovirus enhancer, 21 was used. During the exponential growth phase, 45CB1 and 28CB2 cells were plated in 6-well culture plates at a density of 5 ϫ 10 5 cells/well 24 hours before Adex1CAlacZ infection. Immediately before infection, the culture medium was removed, and suspensions of Ad were added over the monolayers at various multiplicities of infection (MOIs) (from 0 to 100). After a 24-hour incubation with complete culture medium, ␤-gal expression was evaluated using 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (XGal) as the substrate, as described previously. 19 Detection of Cre-loxP-based DNA recombination and recombinant bax expression Cells were lysed with 0.5% sodium dodecyl sulfate and 100 g/mL proteinase K. DNA was extracted from the lysates with phenol/chloroform (1:1 vol/vol), precipitated with ethanol, and dissolved in 10 mM tris(hydroxymethyl)aminomethane (Tris)-HCl (pH 7.5) and 1 mM ethylenediaminetetraacetic acid. A total of 1 g of DNA was subjected to 35 cycles of PCR amplification, with each cycle consisting of 1 minute at 94°C, 1 minute at 64°C, and 2 minutes at 72°C using a DNA Thermal cycler 480 (Perkin Elmer Cetus, Branchburg, NJ). The primers used for amplification of the sequences within the bax gene were BA1 (5Ј-AGCTGCAGAGGATGATTGCC-3Ј) and BA2 (5Ј-ACAAAGATGGTCACGGTCTG-3Ј); the sequences between the CAG promoter and the Bax cDNA were CA1 (5Ј-CTGCTAACCATGTTCATGCC-3Ј) and BA3 (5Ј-CTC-CATGTTACTGTCCAGTTC-3Ј).
For RT-PCR analysis, mRNA was isolated from cells using the QuickPrep mRNA purification kit (Pharmacia, Piscataway, NJ). First-strand cDNA was generated from 120 ng of mRNA with the First-Strand cDNA Synthesis Kit (Pharmacia). A total of 35 cycles of amplification were carried out, each of which consisted of denaturation (1 minute at 94°C), annealing (1 minute at 62°C), and primer extension (1 minute at 72°C). The primers used to amplify the sequences between the area upstream of the splice donor in the CAG promoter and the Bax cDNA were CA2 (5Ј-CTCTGACTGACCGCGTTACT-3Ј) and BA3. The primers used to amplify the sequences of ␤-actin mRNA were AC1 (5Ј-GAGCTGCGTGTGGCTCCC-3Ј) and AC2 (5Ј-TGGCATGGGGGAGGGCATA-3Ј); the primers used to amplify the sequences specific to endogenous Bax mRNA were BA3 and BA4 (5Ј-AGGCGGCGGCGGG-AGCGG-3Ј).
For Northern blot analysis, total RNA was extracted using Isogen (Nippon Gene, Toyama, Japan). A total of 15 g of total RNA was separated on a 1% agarose gel containing 0.66 M formaldehyde, transferred onto a nylon membrane filter (Amersham, Arlington Heights, Ill), and probed with 32 Plabeled human bax-␣ full-length cDNA and human ␤-actin cDNA (Wako, Osaka, Japan). infection, Adex1CAlacZ 24 infection, or a mock infection. Immediately before infection, the culture medium was removed from the wells, and suspensions of AdCAG-Cre or Adex1CAlacZ at a MOI of 20 were placed onto the cell monolayers for 1 hour. The cells were then cultured in complete medium. After incubating for 24, 48, and 72 hours, cell viability was determined by the MTT assay (Cell Proliferation Kit I, Boehringer Mannheim), which measures viable cell dehydrogenase activity. 25 Absorbance of the fluid was read on a model 450 microplate reader (Bio-Rad). Cell proliferation was proportional to the absorbance at the test wavelength (550 nm) minus the absorbance at the reference wavelength (695 nm). The cell viability on each day was expressed as the absorbance relative to that at 0 hours.
Analysis of DNA fragmentation
DNA fragmentation was analyzed by agarose gel electrophoresis. Cells (2 ϫ 10 6 ) were plated in 6-cm dishes and incubated the following day with Ad vectors (at a MOI of 20) for 48 hours. Both adherent and floating cells were collected, pelleted by centrifugation, and incubated in 0.1 mL of 10 mM Tris-HCl (pH 7.4) containing 10 mM ethylenediaminetetraacetic acid and 0.5% Triton X-100 at 4°C for 10 minutes. Samples were subsequently microfuged at 4°C for 10 minutes at 13,000 ϫ g, and the supernatants were incubated for 1 hour at 37°C with ribonuclease A (final concentration 0.4 mg/mL). Next, 2 L of 20 mg/mL proteinase K was added, and incubation was continued for 1 hour. The DNA was then purified and analyzed by electrophoresis in 2.0% agarose gels. The DNA in the gels was visualized under ultraviolet light after staining with ethidium bromide.
Transient transfection into MKN-45 cells and analysis by X-Gal staining
The expression plasmid vectors pCAGBax and pCAG␤GN (a generous gift of Dr. K. Mitani, University of California Los Angeles School of Medicine, Los Angeles, Calif), which harbor the human bax-␣ or lacZ (with a nuclear localization signal) genes under the transcriptional control of the ␤-actin promoter and cytomegalovirus enhancer, 21 were used for transient transfection into MKN-45 cells. MKN-45 cells (5 ϫ 10 5 ) were plated on 35-mm dishes and transfected with 2.5 g of pCAGBax or empty pCXN2 plasmid and 0.25 g of pCAG␤GN plasmid using the calcium-phosphate method. 23 After 48 hours, cell monolayers were washed twice with phosphate-buffered saline (PBS), and the adherent cells were fixed with 0.2% glutaraldehyde in PBS. ␤-gal activity was detected using X-Gal as a substrate, as described previously. 19 The number of cells with a blue-stained nucleus was determined by microscopic examination. Total RNA was extracted from cells using Isogen (Nippon Gene), and RT-PCR was performed using the GeneAmp RNA PCR kit (Perkin Elmer Cetus). The primers CA2 and BA3 were used to detect exogenous Bax mRNA; the primers AC1 and AC2 were used to detect ␤-actin mRNA.
Drug sensitivity of the cells after the induction of bax
To evaluate the death-promoting activity of Bax in the presence of antitumor drugs, the Bax-induced 28CB2 clone (B-28CB2) and the parental 28CB2 clone (P-28CB2) were compared. B-28CB2 and P-28CB2 cells were seeded into 96-well plates at a density of 1 ϫ 10 4 cells in 100 L of medium per well and incubated for 24 hours to induce all of the tumor cells to enter the exponential growth phase. A total of 100 L of medium containing various concentrations of drugs was then added to each well. Four agents were used: CDDP, mitomycin C (MMC), etoposide (VP-16), and camptotecin (CPT) (Sigma). The plates were incubated for 24 hours, and cells were washed once with PBS and incubated for an additional 48 hours in drug-free medium. The antitumoral activity of the drugs was evaluated by the MTT assay as described above. The concentration of each drug yielding 50% inhibition of cell growth (IC 50 ) was calculated using a curve-fitting algorithm.
Data analysis
The Mann-Whitney U test and the two-tailed Student's t test were applied when appropriate.
RESULTS
Efficiency of Ad-mediated gene transfer in MKN cells
To test the efficiency of the Ad-mediated gene transfer, 45CB1 and 28CB2 cells were infected with Adex1CAlacZ at various MOIs. At a MOI of 20, lacZ gene expression was detected in Ͼ90% of the cells of both lines at 24 hours postinfection (data not shown).
Establishment of inducible bax transfectant clones derived from MKN-45 and MKN-28 gastric cancer cells
To examine the effects of Bax overexpression in gastric cancer cells, we first produced MKN-45 and MKN-28 transfectants bearing an expression plasmid, pCAG-CAT-bax-neo, which directs expression of the bax gene upon Cre-mediated excision of the loxP-flanked CAT gene located between the CAG promoter and the bax gene. Several transfectant clones were tested for their expression levels of the CAT gene. Clone 45CB1, which was derived from MKN-45, and clone 28CB2, which was derived from MKN-28, were found to express high levels of CAT and were used in the subsequent study. These clones did not express Bax mRNA until they were induced to express it upon infection with the Creexpressing Ad vector AdCAG-Cre. 19 Detection of Cre-loxP-based DNA recombination and induction of bax gene expression To confirm that the Cre-loxP-based DNA recombination occurred in the 45CB1 and 28CB2 cells after AdCAGCre infection, PCR and RT-PCR analyses were performed. DNA was extracted from each kind of tumor cell 24 hours after infection with AdCAG-Cre or Adex1CAlacZ at a MOI of 20. The 5Ј primer CA1 and the 3Ј primer BA3 were designed to hybridize with the junctional sequence between the CAG promoter and the bax gene (Fig 1A) . Amplification of DNA from AdCAGCre-infected cells using these primers produced a DNA fragment of 400 bp, whereas this DNA fragment was not amplified from the DNA of Adex1CAlacZ-infected cells, although both DNAs produced the same 300-bp fragment by PCR, using primers BA1 and BA2 (Fig 2A) . Next, mRNA was extracted from tumor cells at 8 and 24 hours after infection with AdCAG-Cre or Adex1CAlacZ. To amplify the junctional sequences, the 5Ј primer CA2 and the 3Ј primer BA3 were used ( Fig  1B) . A 400-bp fragment was amplified from the cells infected with AdCAG-Cre at 8 and 24 hours. This 5Ј primer was designed to hybridize with the upstream sequence of the splicing donor site. Therefore, this 400-bp fragment was specific for the mRNA from the recombined transgene. It was not amplified from the mRNA of Adex1CAlacZ-infected cells, although both mRNAs produced the same 250-bp fragment specific for ␤-actin mRNA (Fig 2B) . These results indicate that the AdCAG-Cre infection efficiently induced Bax expression through the Cre-mediated excision of the CAT gene sequence from the CAG-CAT-bax transgene.
Northern blot analysis revealed that the expression levels of Bax mRNA, compared with ␤-actin mRNA, increased ϳ2-fold in 45CB1 cells and ϳ3-fold in 28CB2 cells at 24 hours after AdCAG-Cre infection (Fig 3A) . To distinguish endogenous and exogenous Bax mRNAs, both of which were the same size (1.0 kb), RT-PCR was performed using the 5Ј primer CA2 or BA4 and the 3Ј primer BA3. Only the mRNA derived from the exog-enously transfected bax gene (CAGBax) increased after AdCAG-Cre infection (Fig 3B) .
Effect of Cre-mediated bax gene activation on MKN cells
To analyze the effect of bax gene activation on cell viability, 45CB1 and 28CB2 cells were either infected with AdCAG-Cre or Adex1CAlacZ at a MOI of 20 or mock-infected and cultured for 3 days. The MTT assay was performed each day thereafter to determine cell viability over time. In Bax-expressing 45CB1 cells, decreased proliferation was seen up to day 3, compared with 45CB1 cells that were infected with Adex1CAlacZ or mock-infected (Fig 4A) . In contrast, Bax-expressing 28CB2 cells showed decreased proliferation only on day 1 (compared with cells infected with Adex1CAlacZ), and up to day 2 (compared with mock-infected cells) (Fig 4B) . There was no significant difference in viability between the cells infected with Adex1CAlacZ and the mock-infected cells. The morphological changes seen in the Bax-expressing cells were cell shrinkage and fragmentation, which were usually associated with apoptotic cell death (Fig 5A) . In addition, agarose gel electrophoresis revealed that DNA fragmentation occurred in 45CB1 cells after infection with AdCAG-Cre, but not after infection with Adex1CAlacZ (Fig 5B) . These results indicated that the decreased growth rate after the induction of bax expression was caused at least in part by the increasing rate of spontaneous apoptosis in these cells.
Transient transfection with bax into MKN-45 cells
In the previous experiment, decreased proliferation was seen in 45CB1 cells after the induction of bax expression, and we speculated that this decreased proliferation was caused by an increase in spontaneous apoptosis. Therefore, overexpressed Bax might trigger cell death by itself in 45CB1 cells. To examine this possibility, we cotrans- (Fig 6) . We conclude, therefore, that Bax expression in MKN-45 cells leads to increased cell death.
Induction of bax expression sensitizes 28CB2 cells to some chemotherapeutic drugs As shown in Figure 4B , Bax-expressing 28CB2 cells showed no significant difference in cell proliferation compared with uninduced 28CB2 cells after day 3 and were considered to stably express Bax. We examined the sensitivity of these cells to various chemotherapeutic agents. Bax-induced 28CB2 cells (B-28CB2) that had been infected with AdCAG-Cre showed increased sensitivity to some chemotherapeutic agents (Fig 7) , with a significant decrease in the IC 50 of CDDP (P Ͻ .001), MMC (P Ͻ .005), and CPT (P Ͻ .001) compared with parent 28CB2 cells (P-28CB2). However, B-28CB2 cells did not show any change in sensitivity to VP-16.
DISCUSSION
Previous studies have shown that stable expression of Bax is permissive for apoptosis but does not necessarily induce death in mammalian cells. 3, 13, 14, 17 However, it has been shown that Bax expression was sufficient to induce apoptosis in Jurkat cells, using a reverse tetracycline-inducible system, 26 and in some mammalian cells that were transiently transfected. 11, 15, 27 These different results are partly attributable to differences in the experimental systems. In stable transfection, highly expressing clones may be lost when the product of the transfected gene is toxic to the cell, or some other protein may be overproduced to counteract the effects of this product on the selection process. Because of these potential problems, rather than investigating the effects of a stable overexpression of Bax, we studied Bax expression in gastric cancer cells using a Cre-loxP-based DNA recombination system. 19 The results obtained using this system indicated that enhanced Bax expression reduced cell proliferation in gastric cancer cells, and especially in MKN-45 cells. We did not perform cell cycle analysis, but assumed that the decreased proliferation was partially caused by a higher rate of cell death, because more dead cells and DNA ladders were seen in Bax-induced cells than were seen in Adex1CAlacZ-infected cells. In a previous report using stable Bax overexpression in a rat glioma cell line, a decreased growth rate and increased rate of spontaneous apoptosis were seen in the baxtransfected cells. 16 Moreover, the transient transfection assay in this study also supported the idea that overexpressed Bax induced cell death in MKN-45 cells. However, the Bax-mediated reduction of lacZ-positive cells in the transient transfection assay seemed greater than the reduction with Cre-loxP-mediated Bax-expressing cells. We speculate that this difference is due to different amounts of Bax expression. We could not determine the Bax expression level in the transient transfection assay, but many copies of plasmid DNA were likely taken up by the cells with the calcium-phosphate coprecipitation procedure. Conversely, the bax induction level in the 45CB1 clone was not very high (2-fold, as assessed by Northern blotting). Therefore, only high levels of Bax expression may accelerate cell death in MKN-45 cells. Bax may not be a potent promoter of apoptosis as reported previously. 15, 16 In addition, characteristics of the target cells may greatly affect the outcome of Bax overexpression. In previous studies using a reverse tetracycline-inducible system, Bax expression was able to induce apoptosis in Jurkat cells, 26 but it was not sufficient to induce apoptosis in R30C and MCF-7 breast cancer cells. 12 In our study, the reduced cell proliferation after bax induction was clearly observed in MKN-45 (45CB1) cells but was only transiently in MKN-28 (28CB2) cells. These differences may be due in part to the expression levels of Bcl-2 in each cell line: MKN-45 has no detectable Bcl-2, whereas MKN-28 has it at high levels. 5 The levels of Bax in MKN-28 cells are probably similar or rather low compared with MKN-45 cells (see Bax mRNA levels at 0 hours in Fig 3A) . Therefore, the ratio of Bcl-2 to Bax is probably higher in MKN-28 cells compared with MKN-45 cells. A previous report showed that overexpression of Bcl-2 increased the half-life of Bax in a leukemia cell line, and suggested the existence of a feedback mechanism that may help to maintain the ratio of Bcl-2 to Bax protein in a physiologically appropriate range. 28 Therefore, it is possible that Bax turnover was accelerated by Bax overexpression in MKN-28 cells, although this may not fully explain the difference in the 4 cells/well in 96-multiwell plates and exposed to various concentrations (0 -100 g/mL) of each drug for 24 hours. At 48 hours postincubation, the number of viable cells was measured by MTT assay. The IC 50 was calculated using a curve-fitting algorithm, and the data indicate the mean Ϯ SD for triplicate determinations. The Bax-induced clone showed a decrease in the IC 50 of CDDP (P Ͻ .001), MMC (P Ͻ .005), and CPT (P Ͻ .001), but not in the IC 50 Initial reports of experiments with Bax overexpression in breast and ovarian carcinomas demonstrated dramatic increases in sensitivity to chemotherapeutic agents. [12] [13] [14] Our study showed that overexpression of Bax also sensitized MKN-28 gastric cancer cells to treatment with CDDP, and with MMC and CPT, although weakly. In particular, the sensitivity to treatment with CDDP was nearly doubled. Previous reports showed that Bax could sensitize breast cancer cells 13 and lymphoid cells 29 to CDDP-induced cell death. CDDP is thought to act analogously to alkylating agents. Overexpressed Bax may sensitize the cells suffering from DNA damage caused by DNA alkylation. Overexpression of Bcl-2 and/or mutation of the p53 gene was implicated in the CDDP resistance in ovarian cancer cells. 30, 31 Because MKN-28 cells overexpress Bcl-2 protein and have a mutated p53 gene, overexpressed Bax might have bypassed the need for the upstream signal molecules such as p53. However, Bax overexpression failed to sensitize human ovarian cancer cells lacking functional p53 to another platinum analog (carboplatin). 14 However, Bax overexpression did not sensitize MKN-28 cells to etoposide/VP-16 in our study. Previously, two studies reported that Bax overexpression failed to sensitize human ovarian tumor cells 14 or erythroleukemia cells 15 to etoposide/VP-16-induced apoptosis despite sensitizing these cells to some other agents. In contrast, other investigators have reported that Bax could sensitize these cells to etoposide/VP-16. 13, 29 Thus, it remains to be elucidated whether Bax overexpression has differential effects on CDDP-and etoposide/VP-16-induced apoptosis among different cells.
The Cre-loxP-based recombination system has been used extensively for tissue-specific gene activation or deletion in transgenic mice 32 and for excision, integration, and translocation of cellular genomes in eukaryotic cells. 33, 34 Sakai et al 19 reported efficient regulation of gene expression using the Cre-expressing Ad vector in mammalian cells stably transfected with the lacZ reporter gene. In the present study, we also showed that the AdCAG-Cre vector could be effectively used to activate the bax gene in human gastric cancer cell lines. Therefore, the combination of the loxP-based on/off switching unit and the AdCAG-Cre vector is a very useful tool for manipulating the expression of a gene whose product may be toxic to cells. In addition, this system is also useful for comparing the pre-gene-expressing state with the post-gene-expressing state in the same cell.
Many new antitumoral therapies have focused on the mechanisms of inducing apoptosis. 1 Therefore, it is important to investigate the outcomes of exogenously modulated apoptosis-regulating genes in cancer cells. In this study, we showed that Bax overexpression in gastric cancer cells resulted in decreased proliferation and increased sensitivity to CDDP. These pro-apoptotic effects of Bax may prove beneficial in reducing tumors. Thus, up-regulation of the bax gene could be expected to be a useful strategy for the treatment of gastric cancer.
